Skip to main content

Table 2 Incidence of DVT and major bleeding

From: IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics

THA/TKA

drug

No. patients

No. DVT(%)

No. bleeding(%)

THA

UFH

60

6(10.0)

3(5.0)

 

LMWH

64

6(9.4)

1(1.6)

 

Fondaparinux

49

4(8.2)

3(6.1)

 

others

41

5(12.2)

1(2.4)

TKA

UFH

44

10(22.7)

5(11.4)

 

LMWH

31

8(25.8)

2(6.5)

 

Fondaparinux

32

4(12.5)

0(0)

 

others

53

13(24.5)

5(9.4)

  1. Abbreviations: DVT; deep vein thrombosis, TKA; total knee arthroplasty, THA; total hip arthroplasty, UFH; unfractionated heparin, LMWH; low-molecular weight heparin